aluates Reports

$ 0.0

Automative

Global Post-Traumatic Stress Disorder Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-36A13464

Global Post Traumatic Stress Disorder Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Post-Traumatic Stress Disorder Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-36A13464

Report

December 2024

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

GlaxoSmithKline PLC

Otsuka Pharmaceutical Co Ltd

Novartis

Astrazeneca plc

Azevan Pharmaceuticals Inc

Bionomics Ltd

Tonix Pharmaceuticals Holding Corp.

Apotex

Post-Traumatic Stress Disorder Therapeutics Market Size

The global Post-Traumatic Stress Disorder Therapeutics market is projected to grow from US$ 2512.5 million in 2024 to US$ 3135.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.

Post-Traumatic Stress Disorder Therapeutics Market

The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.

Market Analysis and Insights: Global Post-Traumatic Stress Disorder Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Post-Traumatic Stress Disorder Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Post-Traumatic Stress Disorder Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Post-Traumatic Stress Disorder Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Post-Traumatic Stress Disorder Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Post-Traumatic Stress Disorder Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Post-Traumatic Stress Disorder Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Post-Traumatic Stress Disorder Therapeutics Market Report

Report Metric	Details
Report Name	Post-Traumatic Stress Disorder Therapeutics Market
Accounted market size in 2024	US$ 2512.5 million
Forecasted market size in 2030	US$ 3135.3 million
CAGR	3.8
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Antidepressants Anti-Anxiety Drugs Others
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd, Novartis AG, AstraZeneca Plc, Azevan Pharmaceuticals, Inc., Bionomics Ltd., Tonix Pharmaceuticals Holding Corp., Apotex, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Post-Traumatic Stress Disorder Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Post-Traumatic Stress Disorder Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Post-Traumatic Stress Disorder Therapeutics Market growing?

Ans: The Post-Traumatic Stress Disorder Therapeutics Market witnessing a CAGR of 3.8 during the forecast period 2025-2030.

What is the Post-Traumatic Stress Disorder Therapeutics Market size in 2030?

Ans: The Post-Traumatic Stress Disorder Therapeutics Market size in 2030 will be US$ 3135.3 million.

Who are the main players in the Post-Traumatic Stress Disorder Therapeutics Market report?

Ans: The main players in the Post-Traumatic Stress Disorder Therapeutics Market are Pfizer, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd, Novartis AG, AstraZeneca Plc, Azevan Pharmaceuticals, Inc., Bionomics Ltd., Tonix Pharmaceuticals Holding Corp., Apotex, Inc.

What are the Application segmentation covered in the Post-Traumatic Stress Disorder Therapeutics Market report?

Ans: The Applications covered in the Post-Traumatic Stress Disorder Therapeutics Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Post-Traumatic Stress Disorder Therapeutics Market report?

Ans: The Types covered in the Post-Traumatic Stress Disorder Therapeutics Market report are Antidepressants, Anti-Anxiety Drugs, Others

Recommended Reports

Mental Health Therapeutics

Neurodegenerative Diseases

Cardiovascular and Critical Care

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Antidepressants

1.2.3 Anti-Anxiety Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Perspective (2019-2030)

2.2 Global Post-Traumatic Stress Disorder Therapeutics Growth Trends by Region

2.2.1 Post-Traumatic Stress Disorder Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Post-Traumatic Stress Disorder Therapeutics Market Dynamics

2.3.1 Post-Traumatic Stress Disorder Therapeutics Industry Trends

2.3.2 Post-Traumatic Stress Disorder Therapeutics Market Drivers

2.3.3 Post-Traumatic Stress Disorder Therapeutics Market Challenges

2.3.4 Post-Traumatic Stress Disorder Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Post-Traumatic Stress Disorder Therapeutics by Players

3.1.1 Global Post-Traumatic Stress Disorder Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Post-Traumatic Stress Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Post-Traumatic Stress Disorder Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio

3.4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Therapeutics Revenue in 2023

3.5 Global Key Players of Post-Traumatic Stress Disorder Therapeutics Head office and Area Served

3.6 Global Key Players of Post-Traumatic Stress Disorder Therapeutics, Product and Application

3.7 Global Key Players of Post-Traumatic Stress Disorder Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Type

4.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2025-2030)

5 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Application

5.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

6.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type

6.2.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

6.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application

6.3.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

6.4 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country

6.4.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

7.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type

7.2.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

7.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application

7.3.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

7.4 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country

7.4.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

8.2 China Post-Traumatic Stress Disorder Therapeutics Market Size by Type

8.2.1 China Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024)

8.2.2 China Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030)

8.2.3 China Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

8.3 China Post-Traumatic Stress Disorder Therapeutics Market Size by Application

8.3.1 China Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024)

8.3.2 China Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030)

8.3.3 China Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

9.2 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type

9.2.1 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

9.3 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application

9.3.1 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

9.4 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Region

9.4.1 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer, Inc.

11.1.1 Pfizer, Inc. Company Details

11.1.2 Pfizer, Inc. Business Overview

11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction

11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.1.5 Pfizer, Inc. Recent Developments

11.2 GlaxoSmithKline plc

11.2.1 GlaxoSmithKline plc Company Details

11.2.2 GlaxoSmithKline plc Business Overview

11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Introduction

11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.2.5 GlaxoSmithKline plc Recent Developments

11.3 Otsuka Pharmaceutical Co., Ltd

11.3.1 Otsuka Pharmaceutical Co., Ltd Company Details

11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview

11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Introduction

11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Details

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Post-Traumatic Stress Disorder Therapeutics Introduction

11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.4.5 Novartis AG Recent Developments

11.5 AstraZeneca Plc

11.5.1 AstraZeneca Plc Company Details

11.5.2 AstraZeneca Plc Business Overview

11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Introduction

11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.5.5 AstraZeneca Plc Recent Developments

11.6 Azevan Pharmaceuticals, Inc.

11.6.1 Azevan Pharmaceuticals, Inc. Company Details

11.6.2 Azevan Pharmaceuticals, Inc. Business Overview

11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction

11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.6.5 Azevan Pharmaceuticals, Inc. Recent Developments

11.7 Bionomics Ltd.

11.7.1 Bionomics Ltd. Company Details

11.7.2 Bionomics Ltd. Business Overview

11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Introduction

11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.7.5 Bionomics Ltd. Recent Developments

11.8 Tonix Pharmaceuticals Holding Corp.

11.8.1 Tonix Pharmaceuticals Holding Corp. Company Details

11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview

11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Introduction

11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Developments

11.9 Apotex, Inc.

11.9.1 Apotex, Inc. Company Details

11.9.2 Apotex, Inc. Business Overview

11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction

11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

11.9.5 Apotex, Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

GlaxoSmithKline PLC

Otsuka Pharmaceutical Co Ltd

Novartis

Astrazeneca plc

Azevan Pharmaceuticals Inc

Bionomics Ltd

Tonix Pharmaceuticals Holding Corp.

Apotex

List of Tables

Table 1. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Antidepressants

Table 3. Key Players of Anti-Anxiety Drugs

Table 4. Key Players of Others

Table 5. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2019-2024)

Table 9. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2025-2030)

Table 11. Post-Traumatic Stress Disorder Therapeutics Market Trends

Table 12. Post-Traumatic Stress Disorder Therapeutics Market Drivers

Table 13. Post-Traumatic Stress Disorder Therapeutics Market Challenges

Table 14. Post-Traumatic Stress Disorder Therapeutics Market Restraints

Table 15. Global Post-Traumatic Stress Disorder Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Post-Traumatic Stress Disorder Therapeutics Revenue Share by Players (2019-2024)

Table 17. Global Top Post-Traumatic Stress Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2023)

Table 18. Global Post-Traumatic Stress Disorder Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Post-Traumatic Stress Disorder Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Post-Traumatic Stress Disorder Therapeutics, Product and Application

Table 22. Global Key Players of Post-Traumatic Stress Disorder Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Post-Traumatic Stress Disorder Therapeutics Revenue Share by Application (2019-2024)

Table 30. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Post-Traumatic Stress Disorder Therapeutics Revenue Share by Application (2025-2030)

Table 32. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Post-Traumatic Stress Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Post-Traumatic Stress Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Post-Traumatic Stress Disorder Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 64. Pfizer, Inc. Company Details

Table 65. Pfizer, Inc. Business Overview

Table 66. Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Product

Table 67. Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Pfizer, Inc. Recent Developments

Table 69. GlaxoSmithKline plc Company Details

Table 70. GlaxoSmithKline plc Business Overview

Table 71. GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Product

Table 72. GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 73. GlaxoSmithKline plc Recent Developments

Table 74. Otsuka Pharmaceutical Co., Ltd Company Details

Table 75. Otsuka Pharmaceutical Co., Ltd Business Overview

Table 76. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Product

Table 77. Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Otsuka Pharmaceutical Co., Ltd Recent Developments

Table 79. Novartis AG Company Details

Table 80. Novartis AG Business Overview

Table 81. Novartis AG Post-Traumatic Stress Disorder Therapeutics Product

Table 82. Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 83. Novartis AG Recent Developments

Table 84. AstraZeneca Plc Company Details

Table 85. AstraZeneca Plc Business Overview

Table 86. AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Product

Table 87. AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 88. AstraZeneca Plc Recent Developments

Table 89. Azevan Pharmaceuticals, Inc. Company Details

Table 90. Azevan Pharmaceuticals, Inc. Business Overview

Table 91. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Product

Table 92. Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Azevan Pharmaceuticals, Inc. Recent Developments

Table 94. Bionomics Ltd. Company Details

Table 95. Bionomics Ltd. Business Overview

Table 96. Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Product

Table 97. Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Bionomics Ltd. Recent Developments

Table 99. Tonix Pharmaceuticals Holding Corp. Company Details

Table 100. Tonix Pharmaceuticals Holding Corp. Business Overview

Table 101. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Product

Table 102. Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Tonix Pharmaceuticals Holding Corp. Recent Developments

Table 104. Apotex, Inc. Company Details

Table 105. Apotex, Inc. Business Overview

Table 106. Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Product

Table 107. Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024) & (US$ Million)

Table 108. Apotex, Inc. Recent Developments

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Antidepressants Features

Figure 4. Anti-Anxiety Drugs Features

Figure 5. Others Features

Figure 6. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Post-Traumatic Stress Disorder Therapeutics Report Years Considered

Figure 12. Global Post-Traumatic Stress Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Post-Traumatic Stress Disorder Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Players in 2023

Figure 16. Global Top Post-Traumatic Stress Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue in 2023

Figure 18. North America Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

Figure 20. North America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

Figure 21. North America Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2019-2030)

Figure 22. United States Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

Figure 26. Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

Figure 27. Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2019-2030)

Figure 28. Germany Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

Figure 36. China Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

Figure 37. Asia Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

Figure 39. Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

Figure 40. Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2019-2030)

Figure 41. Japan Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Country (2019-2030)

Figure 51. Brazil Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 58. GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 59. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 60. Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 61. AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 62. Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 63. Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 64. Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 65. Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Post traumatic Stress Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Post Traumatic Stress Disorder PTSD Market Research Report 2024

Global Anxiety Disorders Treatment Market Insights Forecast to 2030

Global Burn Therapy Market Insights Forecast to 2030

Global Acute Agitation and Aggression Treatment Market Insights Forecast to 2030

Global General Anxiety Disorder Therapeutics Market Research Report 2025

Global Burn Care Treatment Market Insights Forecast to 2030

Global Mental Health Technology Market Insights Forecast to 2030

Global Postoperative Pain Therapeutics Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Osteoporosis Treatment Market Insights Forecast to 2030

Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030

Global Non Opioid Pain Treatment Market Insights Forecast to 2030

Global Mental Health Care Software and Services Market Insights Forecast to 2030

Global Antidepressants Drugs Market Insights Forecast to 2030

Global Poliomyelitis Therapeutics Market Insights Forecast to 2030

Generalized Anxiety Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Weight Loss Therapeutics Market Insights Forecast to 2030

Global Staphylococcal Infection Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions